Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

TRAW

Traws Pharma (TRAW)

Traws Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRAW
DataHoraFonteTítuloCódigoCompanhia
19/02/202518:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
14/02/202518:22Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRAWTraws Pharma Inc
10/02/202518:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
07/02/202522:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
06/02/202518:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TRAWTraws Pharma Inc
31/01/202518:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRAWTraws Pharma Inc
27/01/202518:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TRAWTraws Pharma Inc
23/01/202509:00PR Newswire (US)Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird FluNASDAQ:TRAWTraws Pharma Inc
23/01/202502:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRAWTraws Pharma Inc
15/01/202508:33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TRAWTraws Pharma Inc
10/01/202519:55PR Newswire (US)Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral ProgramNASDAQ:TRAWTraws Pharma Inc
31/12/202419:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TRAWTraws Pharma Inc
30/12/202410:00PR Newswire (US)Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to ApprovalNASDAQ:TRAWTraws Pharma Inc
23/12/202409:00PR Newswire (US)Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird FluNASDAQ:TRAWTraws Pharma Inc
15/11/202418:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TRAWTraws Pharma Inc
14/11/202419:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRAWTraws Pharma Inc
23/10/202418:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TRAWTraws Pharma Inc
15/08/202407:03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TRAWTraws Pharma Inc
07/08/202416:47Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TRAWTraws Pharma Inc
30/07/202416:14Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:TRAWTraws Pharma Inc
17/06/202418:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TRAWTraws Pharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRAW